Changxue Lu

7.0k total citations · 3 hit papers
48 papers, 2.8k citations indexed

About

Changxue Lu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Changxue Lu has authored 48 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 20 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Changxue Lu's work include Prostate Cancer Treatment and Research (27 papers), Thyroid Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Changxue Lu is often cited by papers focused on Prostate Cancer Treatment and Research (27 papers), Thyroid Cancer Diagnosis and Treatment (10 papers) and Radiopharmaceutical Chemistry and Applications (9 papers). Changxue Lu collaborates with scholars based in United States, China and United Kingdom. Changxue Lu's co-authors include Jun Luo, Emmanuel S. Antonarakis, Sheue-yann Cheng, Channing J. Paller, Mario A. Eisenberger, Michael A. Carducci, Hao Wang, Brandon Luber, Samuel R. Denmeade and Mark C. Willingham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Changxue Lu

46 papers receiving 2.8k citations

Hit Papers

Androgen Receptor Splice Variant 7 and Efficacy of Taxane... 2012 2026 2016 2021 2015 2012 2017 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Androgen Receptor Splice Variant 7 and Efficacy of Taxane Chemotherapy in Patients With Metastatic Castration-Resistant Prostate Cancer
    2015 466 citations Emmanuel S. Antonarakis, Changxue Lu et al. profile →
  2. Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer
    2012 451 citations Rong Hu, Changxue Lu et al. Cancer Research profile →
  3. Clinical Significance of Androgen Receptor Splice Variant-7 mRNA Detection in Circulating Tumor Cells of Men With Metastatic Castration-Resistant Prostate Cancer Treated With First- and Second-Line Abiraterone and Enzalutamide
    2017 340 citations Emmanuel S. Antonarakis, Changxue Lu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Changxue Lu United States 25 1.9k 1.1k 900 772 707 48 2.8k
Changmeng Cai United States 29 2.2k 1.1× 1.8k 1.6× 964 1.1× 600 0.8× 503 0.7× 55 3.3k
Minna Balbas United States 7 1.3k 0.7× 731 0.6× 481 0.5× 397 0.5× 289 0.4× 15 1.8k
Holly M. Nguyen United States 21 1.3k 0.7× 934 0.8× 612 0.7× 238 0.3× 598 0.8× 55 2.1k
Christian Palmberg Finland 8 1.6k 0.9× 894 0.8× 550 0.6× 542 0.7× 271 0.4× 13 2.0k
Xiangtian Kong United States 15 1.2k 0.6× 830 0.7× 351 0.4× 318 0.4× 247 0.3× 20 1.8k
Richeng Jiang China 19 1.0k 0.5× 952 0.8× 390 0.4× 246 0.3× 600 0.8× 48 1.8k
Cynthia C.T. Sprenger United States 19 897 0.5× 762 0.7× 499 0.6× 435 0.6× 233 0.3× 31 1.5k
Outi R. Saramäki Finland 21 1.2k 0.6× 1.1k 1.0× 692 0.8× 183 0.2× 318 0.4× 34 1.9k
Donald J. Vander Griend United States 31 1.2k 0.6× 1.5k 1.3× 596 0.7× 243 0.3× 773 1.1× 75 2.7k

Countries citing papers authored by Changxue Lu

Since Specialization
Citations

This map shows the geographic impact of Changxue Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Changxue Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Changxue Lu more than expected).

Fields of papers citing papers by Changxue Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Changxue Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Changxue Lu. The network helps show where Changxue Lu may publish in the future.

Co-authorship network of co-authors of Changxue Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Changxue Lu. A scholar is included among the top collaborators of Changxue Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Changxue Lu. Changxue Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kanayama, Mayuko, Émeline Colomba, Sarah M. Nielsen, et al.. (2025). Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant. Prostate Cancer and Prostatic Diseases.
2.
Lu, Changxue, Kengo Horie, Joseph Cheaib, et al.. (2025). Detection of High-grade Bladder Cancer in Urine Samples Using In Situ Hybridization of Long Noncoding RNA UCA1. Urology. 201. 77–83.
3.
Halabi, Susan, Joseph J. Park, David M. Nanus, et al.. (2024). The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical Cancer Research. 30(6). 1152–1159. 8 indexed citations
4.
Marshall, Catherine H., Lukasz P. Gondek, Changxue Lu, et al.. (2024). Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate. 84(10). 954–958. 10 indexed citations
5.
Kanayama, Mayuko, Yidong Chen, Changxue Lu, et al.. (2023). Clinical and Functional Analyses of an African-ancestry Gain-of-function HOXB13 Variant Implicated in Aggressive Prostate Cancer. European Urology Oncology. 7(4). 751–759. 5 indexed citations
6.
Dong, Liang, Xinxing Du, Changxue Lu, et al.. (2022). RNA profiling of circulating tumor cells systemically captured from diagnostic leukapheresis products in prostate cancer patients. Materials Today Bio. 17. 100474–100474. 6 indexed citations
7.
Wang, Keliang, Jie Luo, Shuyuan Yeh, et al.. (2020). The MAO inhibitors phenelzine and clorgyline revert enzalutamide resistance in castration resistant prostate cancer. Nature Communications. 11(1). 2689–2689. 52 indexed citations
8.
Lu, Changxue, Angelika Terbuch, David Dolling, et al.. (2020). Treatment with abiraterone and enzalutamide does not overcome poor outcome from metastatic castration-resistant prostate cancer in men with the germline homozygous HSD3B1 c.1245C genotype. Annals of Oncology. 31(9). 1178–1185. 32 indexed citations
9.
Brown, Landon C., Changxue Lu, Emmanuel S. Antonarakis, Jun Luo, & Andrew J. Armstrong. (2020). Androgen receptor variant-driven prostate cancer II: advances in clinical investigation. Prostate Cancer and Prostatic Diseases. 23(3). 367–380. 18 indexed citations
10.
Yang, Richard K., Pei Zhao, Changxue Lu, Jun Luo, & Rong Hu. (2018). Expression pattern of androgen receptor and AR-V7 in androgen-deprivation therapy–naïve salivary duct carcinomas. Human Pathology. 84. 173–182. 16 indexed citations
11.
Antonarakis, Emmanuel S., Changxue Lu, Brandon Luber, et al.. (2018). Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. European Urology. 74(2). 218–225. 132 indexed citations
12.
Teply, Benjamin A., Hao Wang, Brandon Luber, et al.. (2017). Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study. The Lancet Oncology. 19(1). 76–86. 137 indexed citations
13.
Guedes, Liana B., Carlos L. Morais, Fawaz Almutairi, et al.. (2016). Analytic Validation of RNA In Situ Hybridization (RISH) for AR and AR-V7 Expression in Human Prostate Cancer. Clinical Cancer Research. 22(18). 4651–4663. 25 indexed citations
14.
Lokhandwala, Parvez M., Lisa Haley, Changxue Lu, et al.. (2016). Analytical Validation of Androgen Receptor Splice Variant 7 Detection in a Clinical Laboratory Improvement Amendments (CLIA) Laboratory Setting. Journal of Molecular Diagnostics. 19(1). 115–125. 41 indexed citations
15.
Hu, Rong, Changxue Lu, Elahe A. Mostaghel, et al.. (2012). Distinct Transcriptional Programs Mediated by the Ligand-Dependent Full-Length Androgen Receptor and Its Splice Variants in Castration-Resistant Prostate Cancer. Cancer Research. 72(14). 3457–3462. 451 indexed citations breakdown →
16.
Fozzatti, Laura, Changxue Lu, Dong‐Wook Kim, & Sheue-yann Cheng. (2011). Differential Recruitment of Nuclear Coregulators Directs the Isoform-Dependent Action of Mutant Thyroid Hormone Receptors. Molecular Endocrinology. 25(6). 908–921. 17 indexed citations
17.
Guigon, Céline J., Laura Fozzatti, Changxue Lu, Mark C. Willingham, & Sheue-yann Cheng. (2010). Inhibition of mTORC1 signaling reduces tumor growth but does not prevent cancer progression in a mouse model of thyroid cancer. Carcinogenesis. 31(7). 1284–1291. 32 indexed citations
18.
Furuya, Fumihiko, Changxue Lu, Céline J. Guigon, & Sheue-yann Cheng. (2008). Nongenomic activation of phosphatidylinositol 3-kinase signaling by thyroid hormone receptors. Steroids. 74(7). 628–634. 39 indexed citations
19.
Furuya, Fumihiko, Changxue Lu, Mark C. Willingham, & Sheue-yann Cheng. (2007). Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer. Carcinogenesis. 28(12). 2451–2458. 87 indexed citations
20.
Lu, Changxue, Edward G. Niles, & Philip T. LoVerde. (2006). Characterization of the DNA-binding properties and the transactivation activity of Schistosoma mansoni nuclear receptor fushi tarazu-factor 1α (SmFTZ-F1α). Molecular and Biochemical Parasitology. 150(1). 72–82. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Changmeng Cai Breakdown of academic impact, for papers by Minna Balbas Breakdown of academic impact, for papers by Holly M. Nguyen Breakdown of academic impact, for papers by Christian Palmberg Breakdown of academic impact, for papers by Xiangtian Kong Breakdown of academic impact, for papers by Richeng Jiang Breakdown of academic impact, for papers by Cynthia C.T. Sprenger Breakdown of academic impact, for papers by Outi R. Saramäki Breakdown of academic impact, for papers by Donald J. Vander Griend
Rankless by CCL
2026